Advanced search
Publication Cover
Näringsforskning Volume 45, 2001 - Issue 1
Journal homepage
5,912
Views
26
CrossRef citations to date
0
Altmetric
Report

Health effects of probiotics and prebiotics A literature review on human studies

Henrik AnderssonDept of Clinical Nutrition, Goteborg University, Sweden.View further author information
(Prof) ,
Nils-Georg AspApplied Nutrition and Food Chemistry, Lund University, Sweden.Correspondence[email protected]
View further author information
(Prof) ,
Åke BruceNational Food Administration, Uppsala, Sweden.View further author information
(Prof) ,
Stefan RoosDept of Microbiology, Swedish University of Agricultural Sciences, Uppsala, Sweden.View further author information
(Dr) ,
Torkel WadströmDept of Medical Microbiology and Infectious Diseases, Lund University, Sweden.View further author information
(Prof) &
Agnes E. WoldDept of Clinical Immunology, Goteborg University, Sweden.View further author information
(Assoc Prof)
Pages 58-75 | Published online: 13 Dec 2016

  • Diplock AT, Aggett PJ, Ashwell M, Bornet F, Fern EB, Roberfroid MB: Scientific concepts of functional foods in Europe: Consensus document. Br J Nutr 1999;81 Suppl. 1:S1-S27.
  • Gibson GR, Roberfroid MB: Dietary modulation of the human colonic microbiota:introducing the concept of prebiotics. J Nutr 1995; 125: 1401–12.
  • Van Loo J et al: Functional food properties of non-digestible oligosaccha-rides: a consensus report from the ENDO project. Brit J Nutr 1999; 81: 121–2.
  • Conway P: Prebiotics and human health: The state-of-the-art and future perspectives. Scand J Nutr 2001; 45: 13–21
  • Wold A: Immune effects of probiotics. Scand J Nutr 2001; 45: 76–85.
  • Mustapha A, Jiang T, Savaiano DA: Improvement of lactose digestion by humans following ingestion of unfermented acidophilus milk: influence of bilesensitivity, lactose transport, and acid tolerance of lactobacillus acidophilus. J Dairy Sci 1997; 80: 1537–45.
  • Montes RG, Bayless TM, Saavedra JM, Perman JA: Effect of milks inoculatedwith Lactobacillus acidophilus or a yogurt starter culture in lactose-maldigestingchildren. J Dairy Sci 1995; 78: 1657–64.
  • Lin MY, Savaiano D, Harladner S: Influence of non-fermented dairy products bacterial starter cultures in lactase maldigestion in humans. JDairy Sci 1991,74: 87-95
  • Vesa TH, Marteau P, Zidi S, Briet F, Pochart P, Rambaud JC: Digestion and tolerance of lactose from yoghurt and different semi- solid fermented dairy products containing Lactobacillus acidophilus and bifidobacteria in lactose maldigesters--is bacterial lactase important? Eur J Clin Nutr 1996; 50: 730–3.
  • Shermak MA, Saavedra JM, Jackson TL, Huang SS, Bayless TM, Ferman JA: Effect of yogurt on symptoms and kinetics of hydrogen production in lactose-malabsorbing children. Am J Clin Nutr 1995; 62: 1003–6.
  • Alm L: Effect of fermentation on lactose, glucose, and galactose content in milk and suitability of fermented milk products for lactose intolerant individuals. J Dairy Sci 1982; 65: 346–52.
  • Teuri U, Vapaatalo El, Korpela R: Fructooligosaccharides and lactulose causemore symptoms in lactose maldigesters and subjects with pseudo-hypolactasia than in control lactose digesters. Am J Clin Nutr 2000; 71: 600–2.
  • Hove.H, Norgaard H, Brobeck Mortensen P: Lactic acid bacteria and the human gastrointestinal tract. Europ J Clin Nutr 1999; 53: 339–50.
  • de Roos NM, Schouten G, Katan MB: Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. EJCN 1999; 53: 277–80.
  • Massey LK: Effect of chanching milk and yogurt consumption on human nutrient intake and serum lipoproteins. J Dairy Sci 1984; 67: 255–62.
  • Lin SY, Ayres JW, Winkler W, Sandine WE: Lactobacillus effects on cholesterol: In vitro and in vivo results. J Dairy Sc 1989; 72: 2885–99.
  • Schaafsma G, Meuling WJ, van Dokkum W, Bouley C: Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligo-saccharides added,on blood lipids in male volunteers, J Clin Nutr 1998; 52: 436-40.
  • Anderson JW, Gilliland SE: Effect of fermented milk (yogurt) containing Lactobacillus acidophilus LI on serum cholesterol in hypercholesterol-emic humans. J Am Coll Nutr 1999; 18: 43–50
  • McNamara DJ, Lowell AE, Sabb JE: Effect of yoghurt intake on plasma lipid and lipoprotein levels in normolipidaemic subjects. Atheriosclerosis 1989; 79: 167–81.
  • Bukowska H, Pieczul-Mroz J, Jastrzebska M, Chelstowski K, Naruszewicz M: Decrease in fibrinogen and LDL-cholesterol levels upon supple-mentation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis 1998; 137: 437–8.
  • Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A: Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000; 54: 288–97.
  • *Agerbaek M, Gerdes LU, Richelsen B: Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. Eur J Clin Nutr 1995; 49: 346–52.
  • *Richelsen B, Kristensen K, Pedersen SB: Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins - a placebo-controlled and double-blind study. Eur J Clin Nutr 1996; 50: 811–5.
  • Bertolami MC, Faludi AA, Batlouni M: Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr 1999; 53: 97–101.
  • Andersson H, Bosaeus I, Ellegard L, Grahn E, Tidehag P, Hallmans G, et al: Effects of low-fat milk and fermented low-fat milk on cholesterol absorp-tion and excretion in ileostomy subjects. Eur J Clin Nutr 1995; 49: 274–81.
  • Taylor GRJ. and Williams CM:Effects of probiotics and prebiotics on blood lipids Brit J Nutr 1998; 80: S225–S230.
  • de Rose NM and Katan MB: Effects of probiotic bacteria on diarrhoea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr 2000; 71: 405–11.
  • Delzenne NM, Williams CM: Actions of non-digestible carbohydrates on serum lipids in humans and animals. In: Gibson GR, Roberfroid MB (ads). Colonic Microbiota, Nutrition and Health. Kluwer Academic Publishers, Dordrecht/Boston/London, 1999;pp 213-31.
  • *Yamashita K, Kawai K, Itakura M: Effects of fructo-oligosaccharides on blood glucose and serum lipids in diabetic subjects. Nutr Res 1984; 4: 961–6.
  • a, Casiraghi MC, Canzi E, Ferrari A: Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr 1999; 53: 726–33.
  • Canzi E, Brighenti F, Casiraghi MC, Del Puppo E, Ferari A: Prolonged consumption of inulin in ready-to-eat breakfast cereals: Effects on intes-tinal ecosystem, bowel habits and lipid metabolism. Cost 92. (Abstract)
  • Davidson MH, Maki KC, Synecki C, Torn SA, Drennan KB: Effects of dietary inulin on serum lipids in men and women with hypercholesterol-emia. Nutr Res 1998; 18: 503–17.
  • Pedersen A, Sandstrom B, Van Amelsvoort JM: The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr 1997; 78: 215–22.
  • Alles MS, de Roos NM, Bakx JC, van de Lisdonk E, Zock PL, Hautvast GA: Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr 1999; 69: 64–9.
  • van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel EG: Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 1999; 53: 1–7.
  • Luo J, Rizkalla SW, Alamowitch C, Boussairi A, Blayo A, Barry J-L, Laffitte A, Guyon F, Bornet FRJ, Slama G: Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucoseproduction but had no effect on insulin-stimulated glucose metabolism 1-3. Am J Clin Nutr 1996; 63: 939-45.
  • Jackson KG, Taylor GR, Clohessy AM, Williams CM: The effect of the daily intake of inulin on fasting lipid and glucose concentrations in middle-aged menand women. Br J Nutr 1999 ; 82: 23–30.
  • Ellegärd L, Andersson H, Bosaeus I: Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increases energy excretion in ileostomy subjects. Eur J Clin Nutr 1997; 51: 1–5.
  • Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T: A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. J Clin Nutr 1996; 64: 767–71.
  • Kawase M: Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J Dairy Sci 2000; 83: 255–62.
  • Ling WH, Hänninen 0, Mykkänen H, Heikura M, Salminen S, Von Wright A: Colonization and fecal enzyme activities after oral Lactobacillus GG administration in elderly nursing home residents. Ann Nutr Metab 1992; 36: 162–6.
  • Benno Y. et al: Effects of Lactobacillus GG yoghurt on human intestinal microecology in Japanese subjects. Nutrition Today Supplement 1996: 331: 9S-11S.
  • Alm L, Humble D, Ryd Kjellen E, Setterberg G: The effect of acidophilus milk in the treatment of constipation in hospitalised geriatric patients. In: Nutr and the intestinal flora. XV Symp Swedish Nutrition Foundation Stockholm: Almqvist & Wiksell International; 1983 ;pp131-8.
  • Cummings JH: The effect of dietary fiber on fecal weight and composition. In: Spiller GA, ed. CRC Handbook of dietary fibre in human nutrition, 2nd ed. Boca Raton, FL:CRC 1993; 263-349.
  • Gibson OR, Beatty ER, Wang X, Cummings JH: Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastro-enterology 1995; 108: 975–82.
  • Alles MS, Hautvast JO, Nagengast FM, Hartemink R, Van Laere KM, Jansen JB. Fate of fructo-oligosaccharides in the human intestine. Br J Nutr 1996; 76: 211–21.
  • Castiglia-Delavaud C, Verdier E, Besle JM, Vernet I, Boirie Y, Beaufrere B, et al. Net energy value of non-starch polysaccharide isolates (sugar beet fibre and commercial inulin) and their impact on nutrient digestive utilization in healthy human subjects. Br J Nutr 1998; 80: 343–52.
  • Kleessen B, Sykura B, Zunft H-J, Blaut M: Effects of inulin and lactose on fecalmicroflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 1997; 65: 1397–1402
  • Newcomer AD, Park HS, O'Brien PC, McGill DB: Response of patients with irritable bowel syndrome and lactase deficiency using unfermented acidophilus milk. Am .1 Clin Nutr 1983; 38: 257–63.
  • *Niedzielin K, Kordecki H, Birkenfeld B: A controlled, double-blind, randomised study on the efficacy of Lactobacillus plantarunz 299v in patients with irritable bowel syndrome. Submitted to the Eur J Gastro-enterol Hepatol 2001 (In press).
  • *Nobaek S. Johansson ML, Molin G, Ahme S. Jeppsson B: Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 1231–8.
  • Saavedra JM and Abi-Hanna A: Clinical studies of probiotic agents. In: Probiotics, Other Nutritional Factors, and Intestinal Microflora (ads L.A. Hanson and R.H. Yolken). Linppincott-Raven publ., Philadelphia. Nestlé Nutrition Workshop Series 1999; 42: 47–61.
  • Pathmakanthan S, Meance S, Edwards CA: Probiotics: A revies of human studies to date and methodological approaches. Microb Ecol Health Dis 2000;suppl 2: 10-30.
  • Isolauri E, Juntunen M, Rautanen T, Sillanaukee P. Koivula T. A: Human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991; 88: 90–7.
  • Kaila M, Isolauri E, Soppi E, Virtanen E, LaMe S, Arvilommi H: Enhan-cement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32: 141–4.
  • Shornikova AV, Casas IA, Isolauri E, Mykkanen H, Vesikari T: Lacto-bacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr 1997; 24: 399–404.
  • Shornikova AV, Casas IA, Mykkanen H, Salo E, Vesikari T: Bacterio-therapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 1997; 16: 1103–7.
  • Colombel JF, Cortot A, Neut C, Romond C: Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987; 2: 43.
  • Orrhage K, Sjostedt S, Nord CE: Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during admi-nistration of cefpodoxime proxetil. J Antimicrob Chemother 2000; 46: 603–12.
  • Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, et al: Effect of Lactobacillus GG yoghurt in prevention of antibiotic-associated diarrhoea. Ann Med 1990; 22: 57–9.
  • Arvola T, Laiho K, Torkkeli S, Mykkanen H, Salminen S, Maunula L, at al.: Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104:64.
  • McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, at al: A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. Jama 1994; 271: 1913–8.
  • Gorbach SL, Chang TW, Goldin B: Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2: 1519. 64. Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL: Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroent Nutr 1995; 21: 224–6.
  • Bennet RG, Gorbach SL, Goldin BR, Chang T-W, Laughon BE, Greenough IWB, et al: Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG. Nutrition Today 1996;31(6, Suppl 1):35S-38S.
  • Johansson ML, Molin G, Jeppsson B, Nobaek S, Ahrné S, Bengmark S: Administration of different Lactobacillus strains in fermented oatmeal soup: in vitro colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol 1993; 59: 15–20.
  • Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A: Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. App! Enivon Microbiol 1999; 65: 351–4.
  • Ahrne S, Nobaek S, Jeppsson B, Adlerberth I, Wold A.E, Molin G: The normal Lactobacillus flora of healthy human oral and rectal mucosa. JAppl Microbiol 1998; 85: 88–94.
  • Vesa T, Pochart P, Marteau P: Pharmacokinetics of Lactobacillus planta-rum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment Pharmacol Ther 2000; 14: 823–8.
  • Rambaud JC, Bouhnik Y, Marteau P, Pochart P: Manipulation of the human gut microflora. Proc Nutr Soc 1993;52;357–66.
  • Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T: Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 1995; 72: 51–3.
  • Ciancio MJ, Chang EB: Epithelial secretory response to inflammation. Ann N Y Acad Sci 1992; 664: 210–21.
  • Rocha MFG, Soares AM, Flores CA, Steiner T.S, Lyerly DM, Guerrant RL, Ribeiro RA, Lima AAM: Intestinal secretory factor released by macro-phages stimulated with Clostridium difficile toxin A: role of interleukin-lb. Infect Immun 1998; 66: 4910–6.
  • Johansson E, Lönnrot I, Lange S eta!: Molecular cloning and expression of a pituitary gland protein modulating intestinal fluid secretion. J Biol Chem 1995; 270: 20615–20.
  • Karlsson S, Lindberg A, NorM E, Burman LG, ;kkerlund T: Toxins, butyric acid, and other short chain fatty acidsare coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun 2000; 68: 5881–8.
  • Michetti P, Dorta G, Wisel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, Corthésy-Theulaz I: Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La 1 on Helicobacter pylori Infection in humans Digestion 1999; 60: 203-209.
  • Canducci F et al: A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000; 14: 1625–9.
  • Gionchetti P, Rizzello F, Venturi A, Brigidi, P. Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli, Campieri M: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305–9.
  • Xavier RJ, Podolsky DK: How to get along - friendly microbes in a hostile world. Science 2000;289;1483–4.
  • Campieri M, Gionchetti P: Probiotics in inflammatory bowel disease. New insight to pathogenesis or a possible therapeutic alternative? Gastroente-rology 1999; 116: 1246–60.
  • Burns AJ, Rowland JR: Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intestinal Microbiol 2000; 1: 13–24 .
  • Hirayama K, Rafter J: The role of probiotic bacteria in cancer prevention. Microbes Infect 2000; 2: 681–6. .
  • Hosoda M, Hashimoto H, He D, Morita H, Hosono A: Effect of admi-nistration of milk fermented with Lactobacillus acidophilus LA-2 on fecal mutagenicity and microflora in the human intestine. J Dairy Sci 1996; 79: 745–9.
  • Aso Y, Akazan H: Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol lot 1992; 49: 125–9.
  • Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S: Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 1995; 27: 104–9.
  • Henriksson R, Franzén L, Sandström K, Nordin A, Arevärn M, Grahn E: Effects of active addition of bacterial cultures in fermented milk to patients with chronic bowel discomfort following irradiation. Support Care Cancer 1995; 3: 81–3.
  • Salminen E, Elomaa, I, Minkkinen J, Vapaatalo H, Salminen S: Pre-servation of intestinal integrity during radiotherapy using live Lacto-bacillus acidophilus cultures. Clin Radio! 1988; 39: 435–7.
  • Otha A, Ohtsuki M, Baba S, Takizawa T, Adachi T, Kimura S: Effect of fructooligosaccharides on the absorption of iron, calcium, and magnesium in iron deficient anemic rats. J Nutr Sci Vitaminology 1995; 41: 281–91.
  • Scholz-Ahrens K, Van Loo J, Schrezenmeyer J: Oligofructose stimuliert die Femurmineralisation in Abhängigkeit von der Calciumzufuhr bei der ovariektomisierten Ratte (The increase in bone mineralization in the ovarectomized rat by oligofructose also depends on Ca supplementation). Zeitschrift für Ernährungswissenschaft 1998; 37: 123–4.
  • *Coudray C, Bellanger J, Castiglia-Delavaud C, Remesy C, Vermorel M, Rayssignuier Y: Effect of soluble or partly soluble dietary fibres supp-lementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men. Eur J Clin Nutr 1997; 51: 375–80.
  • van den Heuvel EG, Schaafsma G, Muys T, van Dokkum W: Nondigestible oligosaccharides do not interfere with calcium and nonheme-iron absorp-tion in young, healthy men. Am J Clin Nutr 1998; 67: 445–51.
  • van den Heuvel EGHM, Muys T, Van Dokkum W, Schaafsma G: Oligo-fructose stimulates calcium absorption in adolescents. Am J Clin Nutr 1999; 69: 544–8.
  • Marteau P: Safety aspects of probiotic products. Scand J Nutr 2001; 45: 22–4.
  • Saxelin M, Chuang NH, Chassy B, Rautelin H, Makeld PH, Salminen S, Gorbach SL: Lactobacilli and bacteriemia in Southern Finland, 1989-1992. Clin Infect Dis 1996; 22: 564–6.
  • Antony, Suresh J: Lactobacillemia: An emerging cause of infection in both the immunocompromised and the immunocompetent host. J Natl Med Assoc 2000; 92: 83–6.
  • Fruchart C, Salah A, Gray C, Martin E, Stamatoulla A, Bonmarchand G, Lemeland IF, Tilly H: Lactobacillus species as emerging pathogens in neutropenic patients. Eur Clin Microbiol Infect Dis 1997; 16: 681–4.
  • Anon: Safety evaluation of fructans.Nordic Council of Ministers, Copenhagen 2000; Temallord 2000:523;pp115.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.